Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The specific aim of this study is to describe 1 year Advair dispensing rates for patients
with COPD, and to measure the association between Advair adherence and healthcare utilization
(e.g. emergency room visits and inpatient admissions, etc.). To compare the risk of a COPD
exacerbation (moderate or severe) during a 3-month follow-up period between patients thqat
are adherent versus those that are not.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Salmeterol Xinafoate Xhance